Publication

Review Articles

2025

• "Rethinking evidence standards for men with metastatic prostate cancer in the post-androgen receptor pathway inhibitor setting: new insights from CONTACT-02"
  Kosuke Takemura, Takeshi Yuasa.
  Transl Androl Urol. 14, 11, 3457-3459 (2025).

  • DOI: 10.21037/tau-2025-701
• "Prevailing challenges in personalized treatment for metastatic renal cell carcinoma: a narrative review"
  Ryosuke Oki, Kosuke Takemura (corresponding author), Tetsuya Urasaki, Ryo Fujiwara, Noboru Numao, Junji Yonese, Yuji Miura, Takeshi Yuasa
  Expert Rev Anticancer Ther. 25, 6, 643-655 (2025).

  • DOI: 10.1080/14737140.2025.2491647.
• "Evaluating the genetic landscape of prostate cancer: new insights from BRCA1/2, ATM and CDK12 mutations"
  Fumihiko Urabe, Kosuke Takemura
  BMJ Oncol. 4, 1, e000717 (2025).

  • DOI: 10.1136/bmjonc-2024-000717.

2024

• "Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review"
  Martin Zarba, Ryo Fujiwara, Takeshi Yuasa, Fumitaka Koga, Daniel Y C Heng, Kosuke Takemura (corresponding author).
  Expert Rev Anticancer Ther. 24, 8, 693-703 (2024).

  • DOI: 10.1080/14737140.2024.2362192.

2023

• "Prognostic factors in advanced renal cell carcinoma: Integrating multidisciplinary treatment for advanced renal cell carcinoma."
  Kosuke Takemura, Vishal Navani, Daniel Y C Heng, Matthew S Ernst.
  Springer, Cham. 10, 233-350 (2023).

  • DOI: 10.1007/978-3-031-40901-1

2021

• "A systematic review of serum γ-glutamyltransferase as a prognostic biomarker in patients with genitourinary cancer"
  Kosuke Takemura, Philip G Board, Fumitaka Koga.
  Antioxidants (Basel). 10, 4, 549 (2021).

  • DOI: 10.3390/antiox10040549